Jeffrey L. Cummings

发表

GAP-NET: SITE NETWORKS FOR EFFICIENT TRIALS RECRUITMENT

Jeffrey L. Cummings, 2016, Alzheimer's & Dementia.

Automated 3d Mapping of Baseline and 12-month Associations between Three Verbal Memory Measures and Hippocampal Atrophy in 490 Adni Subjects and the Alzheimer's Disease Neuroimaging Initiative

Michael Weiner, Liana G. Apostolova, Paul M. Thompson, 2022 .

The review presents strategies for fit-for-purpose method validation of biomarker assays to help ensure generation of robust data during clinical trials and to satisfy regulatory requirements. Fit-for-purpose biomarker method validation inanticancerdrugdevelopment

Jeffrey Cummings, Caroline Dive, Jeffrey L. Cummings, 2010 .

Cordance: A New Method for Assessment of Cerebral Perfusion and Metabolism Using Quantitative Electroencephalography

Robert B. Lufkin, Donald O. Walter, Ian A. Cook, 1994, NeuroImage.

Principles of behavioral and cognitive neurology, 2nd edition

Jeffrey L. Cummings, J. Cummings, 2001 .

Advances in functional magnetic resonance imaging data analysis methods using Empirical Mode Decomposition to investigate temporal changes in early Parkinson's disease

Xiaowei Zhuang, Zhengshi Yang, Virendra Mishra, 2018, Alzheimer's & dementia.

The Human Frontal Lobes: Functions and Disorders

Bruce L. Miller, Jeffrey L. Cummings, J. Cummings, 2013 .

A probabilistic atlas of the human brain in alzheimer's disease: Emerging patterns of variability, asymmetry and degeneration

Paul M. Thompson, Arthur W. Toga, Roger P. Woods, 1999 .

Senile Dementia of the Alzheimer Type

Jeffrey L. Cummings, J. Cummings, 1987 .

Subtle Deficits in Instrumental Activities of Daily Living in Subtypes of Mild Cognitive Impairment

Jeffrey L. Cummings, Ellen Woo, Po H. Lu, 2010, Dementia and Geriatric Cognitive Disorders.

The spectrum of behavioral changes in Alzheimer's disease

Jeffrey L. Cummings, Michael S. Mega, M. Mega, 1996, Neurology.

The Exceptional Brain: Neuropsychology of Talent and Special Abilities

Jeffrey L. Cummings, J. Cummings, 1989 .

Practicality of a computerized system for cognitive assessment in the elderly

Jeffrey L. Cummings, Ely S. Simon, Glen M. Doniger, 2008, Alzheimer's & Dementia.

Definitions and diagnostic criteria

Jeffrey L. Cummings, J. Cummings, 2006 .

Montreal Cognitive Assessment

Natalie A. Phillips, Jeffrey L. Cummings, Howard Chertkow, 2014 .

Cholinesterase Inhibitor Therapies and Neuropsychiatric Manifestations of Alzheimer’s Disease

Jeffrey L. Cummings, J. Cummings, Zakiya J. Wynn, 2003, Dementia and Geriatric Cognitive Disorders.

Klüver‐Bucy syndrome in Pick's disease

Jeffrey L. Cummings, J. Cummings, 1983, Neurology.

Are Unilateral Right Posterior Cerebral Lesions Sufficient to Cause Prosopagnosia? Clinical and Radiological Findings in Six Additional Patients

Theodor Landis, Jeffrey L. Cummings, J. Bogen, 1986, Cortex.

Toward a more precise, clinically—informed pathophysiology of pathological laughing and crying

Jeffrey L. Cummings, J. Cummings, E. Lauterbach, 2013, Neuroscience & Biobehavioral Reviews.

Alzheimer's disease

Reisa A. Sperling, Colin L. Masters, Jeffrey L. Cummings, 2015, Nature Reviews Disease Primers.

Biomarkers in Alzheimer's disease drug development

Jeffrey L. Cummings, J. Cummings, 2011, Alzheimer's & Dementia.

Detecting dynamic (4D) profiles of degenerative rates in Alzheimer's disease patients, using high-resolution tensor mapping and a brain atlas encoding atrophic rates in a population

Paul M. Thompson, Arthur W. Toga, Andrew L. Janke, 2001, NeuroImage.

Alzheimer's disease biomarkers: Correspondence between human studies and animal models

Jefferson W. Kinney, Jeffrey L. Cummings, J. Cummings, 2013, Neurobiology of Disease.

Erratum: 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease (Brain (2006) 127, part 11, (2867-2873) DOI: 10.1093/brain/awl274)

Liana G. Apostolova, Paul M. Thompson, Arthur W. Toga, 2007 .

Surface Feature-Guided Mapping of Cerebral Metabolic Changes in Cognitively Normal and Mildly Impaired Elderly

Liana G. Apostolova, Paul M. Thompson, Arthur W. Toga, 2009, Molecular Imaging and Biology.

Physostigmine ameliorates the delusions of Alzheimer's disease

D. G. Gorman, Jeffrey L. Cummings, Jill Shapira, 1993, Biological Psychiatry.

Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases

Jim Mintz, Jeffrey L. Cummings, George Bartzokis, 2005, Alzheimer's & Dementia.

D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer ’ s disease

Liana G. Apostolova, Paul M. Thompson, Arthur W. Toga, 2006 .

Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options

Jeffrey L. Cummings, Clive Ballard, J. Cummings, 2019, Journal of Alzheimer's disease : JAD.

Positron Emission Tomography in Evaluation of Dementia

Sanjiv S. Gambhir, Gene E. Alexander, Pietro Pietrini, 2001 .

Appendix B: Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology

Bruce L. Miller, Gary W. Small, Jeffrey L. Cummings, 2007 .

Neuropsychiatric aspects of progressive supranuclear palsy

Jeffrey L. Cummings, Irene Litvan, Michael S. Mega, 1996, Neurology.

Comparing the Electronic and Standard Versions of the Montreal Cognitive Assessment in an Outpatient Memory Disorders Clinic: A Validation Study

Jeffrey L. Cummings, Justin B. Miller, J. Cummings, 2018, Journal of Alzheimer's disease : JAD.

Quantitative EEG in Frontotemporal Dementia

Bruce L. Miller, Jeffrey L. Cummings, D. Jenden, 1996, Clinical EEG.

Aphasia in dementia of the Alzheimer type

Jeffrey L. Cummings, Stephen Read, D. Benson, 1985, Neurology.

Contemporary behavioral neurology

Jeffrey L. Cummings, Michael R. Trimble, M. Trimble, 1997 .

Dementia with Lewy bodies

Jeffrey L. Cummings, Douglas W. Scharre, Michael S. Mega, 1996, Neurology.

Speech and language alterations in dementia syndromes: Characteristics and treatment

Jeffrey L. Cummings, D. Benson, J. Cummings, 1990 .

PHASE II CLINICAL TRIAL WITH AN AMPA-POSITIVE ALLOSTERIC MODULATOR (S 47445): BASELINE DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS SUFFERING FROM ALZHEIMER’S DISEASE AT MILD TO MODERATE STAGES WITH DEPRESSIVE SYMPTOMS

Jeffrey L. Cummings, Maria Pueyo, Katy Bernard, 2017, Alzheimer's & Dementia.

Cognitive and behavioral heterogeneity in Alzheimer’s disease: seeking the neurobiological basis

Jeffrey L. Cummings, J. Cummings, 2000, Neurobiology of Aging.

The neuropsychiatry of limbic and subcortical disorders

Jeffrey L. Cummings, Stephen Salloway, Paul Malloy, 1997 .

Integrating ADNI results into Alzheimer's disease drug development programs 1 1 Prepared for a special issue of Neurobiology of Aging on the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Jeffrey L. Cummings, J. Cummings, 2010, Neurobiology of Aging.

Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative

Liana G. Apostolova, Paul M. Thompson, Jeffrey L. Cummings, 2013, Neurobiology of Aging.

Challenges to demonstrating disease-modifying effects in Alzheimer’s disease clinical trials

Jeffrey L. Cummings, J. Cummings, 2006, Alzheimer's & Dementia.

Practice parameter: Diagnosis of dementia (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology

Jeffrey L. Cummings, Jeffrey Kaye, Richard Dubinsky, 2001 .